Health Canada Approves RITUXANŽ Subcutaneous Formulation for Canadians with Chronic Lymphocytic Leukemia

Thursday, March 22, 2018 Cancer News
Email Print This Page Comment bookmark
Font : A-A+

REFERENCES

__________________________

1

Leukemia & Lymphoma Society of Canada. Facts and Statistics. http://www.llscanada.org/disease-information/facts-and-statistics. Last accessed on February 27, 2018.

2

RITUXAN SC Product Monograph. March 21, 2018.

3

Assouline, Sarit et al. Pharmacokinetics, safety, and efficacy of subcutaneous versus intravenous rituximab plus chemotherapy as treatment for chronic lymphocytic leukaemia (SAWYER). Lancet Haematology.2016.

4

Salar A, Avivi I, Bittner B, Bouabdallah R, Brewster M, Catalani O, Follows G, Haynes A, Hourcade-Potelleret F, Janikova A, Larouche JF, McIntyre C, Pedersen M, Pereira J, Sayyed P, Shpilberg O, Tumyan G. 2014. Comparison of subcutaneous versus intravenous administration of rituximab as maintenance treatment for follicular lymphoma: results from a two-stage, phase IB study. J Clin Oncol. 10;32(17):1782-91. doi: 10.1200/JCO.2013.52.2631.

5

Leukemia & Lymphoma Society of Canada. Chronic Lymphocytic Leukemia.http://www.llscanada.org/leukemia/chronic-lymphocytic-leukemia. Last accessed February 26, 2018.

6

Leukemia & Lymphoma Society of Canada. Chronic Lymphocytic Leukemia. http://www.llscanada.org/leukemia/chronic-lymphocytic-leukemia. Last accessed February 26, 2018.

7

Lymphoma Canada. About CLL & SLL. https://www.lymphoma.ca/lymphoma/cll-sll/about-cll-sll. Last accessed on February 26, 2018.

8

RITUXAN SC Product Monograph. March 21, 2018.

9

RITUXAN SC Product Monograph. March 21, 2018.

10

RITUXAN SC Product Monograph. March 21, 2018.

11

RITUXAN SC Product Monograph. March 21, 2018.

12

RITUXAN SC Product Monograph. March 21, 2018.

13

RITUXAN SC Product Monograph. March 21, 2018.

14

RITUXAN SC Product Monograph. March 21, 2018.

Advertisement


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store